{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,12]],"date-time":"2026-03-12T21:31:20Z","timestamp":1773351080866,"version":"3.50.1"},"reference-count":28,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,5,28]],"date-time":"2024-05-28T00:00:00Z","timestamp":1716854400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Hygiene and Environmental Health"],"published-print":{"date-parts":[[2024,7]]},"DOI":"10.1016\/j.ijheh.2024.114402","type":"journal-article","created":{"date-parts":[[2024,6,12]],"date-time":"2024-06-12T03:48:21Z","timestamp":1718164101000},"page":"114402","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["Cyclophosphamide exposure factors in family caregivers for pediatric cancer patients"],"prefix":"10.1016","volume":"260","author":[{"given":"Yuko","family":"Noda","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0056-9988","authenticated-orcid":false,"given":"Yuhki","family":"Koga","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5684-1330","authenticated-orcid":false,"given":"Kenichiro","family":"Yamamura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0001-8030-0518","authenticated-orcid":false,"given":"Junko","family":"Miyata","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0005-5818-5727","authenticated-orcid":false,"given":"Yuko","family":"Hamada","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shouichi","family":"Ohga","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.ijheh.2024.114402_bib1","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1177\/10781552221080445","article-title":"Improved home management of oral pediatric anticancer drugs as a result of an intervention comprising practical training, written instructions and movie clips: a pilot study","volume":"29","author":"Akkawi","year":"2023","journal-title":"J. Oncol. Pharm. Pract."},{"issue":"2","key":"10.1016\/j.ijheh.2024.114402_bib2","first-page":"226","article-title":"Clinical pharmacology of cyclophosphamide","volume":"33","author":"Bagley","year":"1973","journal-title":"Cancer Res."},{"issue":"3","key":"10.1016\/j.ijheh.2024.114402_bib3","doi-asserted-by":"crossref","first-page":"272","DOI":"10.3390\/ph14030272","article-title":"Pharmacokinetics and pharmacogenetics of cyclophosphamide in a neonate and infant childhood cancer patient population","volume":"14","author":"Barnett","year":"2021","journal-title":"Pharmaceuticals"},{"issue":"4","key":"10.1016\/j.ijheh.2024.114402_bib4","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1016\/j.ijheh.2017.03.005","article-title":"Anticancer drug adhesions inside homes of chemotherapy patients","volume":"220","author":"B\u00f6hlandt","year":"2017","journal-title":"Int. J. Hyg Environ. Health"},{"issue":"5","key":"10.1016\/j.ijheh.2024.114402_bib5","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1016\/S1470-2045(16)00086-3","article-title":"Pregnancy after chemotherapy in male and female survivors of childhood cancer treated between 1970 and 1999: a report from the Childhood Cancer Survivor Study cohort","volume":"17","author":"Chow","year":"2016","journal-title":"Lancet Oncol."},{"issue":"1","key":"10.1016\/j.ijheh.2024.114402_bib6","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/S1383-5718(00)00105-4","article-title":"Determination of the vaporization of solutions of mutagenic antineoplastic agents at 23 and 37\u00b0C using a desiccator technique","volume":"470","author":"Connor","year":"2000","journal-title":"Mutat. Res."},{"issue":"1","key":"10.1016\/j.ijheh.2024.114402_bib7","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1080\/00140138108924830","article-title":"Thermal responses to exercise in children","volume":"24","author":"Davies","year":"1981","journal-title":"Ergonomics"},{"issue":"1","key":"10.1016\/j.ijheh.2024.114402_bib8","first-page":"23","article-title":"Aerosol in the oral health-care setting: a misty topic","volume":"27","author":"Fridus","year":"2023","journal-title":"Clin. Oral Invest."},{"issue":"1","key":"10.1016\/j.ijheh.2024.114402_bib9","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1002\/tera.1420400103","article-title":"Effects of phosphoramide mustard and acrolein, cytotoxic metabolites of cyclophosphamide, on mouse limb development in vitro","volume":"40","author":"Hales","year":"1989","journal-title":"Teratology"},{"key":"10.1016\/j.ijheh.2024.114402_bib10","series-title":"Monographs on the Evaluation of Carcinogenic Risks to Humans, Some Antiviral and Antineoplastic Drugs, and Other Pharmaceutical Agents","year":"2012"},{"key":"10.1016\/j.ijheh.2024.114402_bib11","article-title":"Monographs on the identification of carcinogenic hazards to humans","year":"2021","journal-title":"Acrolein, Crotonaldehyde, and Arecoline"},{"key":"10.1016\/j.ijheh.2024.114402_bib12","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.freeradbiomed.2017.05.006","article-title":"Cyclophosphamide and acrolein induced oxidative stress leading to deterioration of metaphase II mouse oocyte quality","volume":"110","author":"Jeelani","year":"2017","journal-title":"Free Radic. Biol. Med."},{"issue":"10","key":"10.1016\/j.ijheh.2024.114402_bib13","article-title":"Interventions to reduce contaminated aerosols produced during dental procedures for preventing infectious diseases","volume":"2020","author":"Kumbargere","year":"2020","journal-title":"Cochrane Database Syst. Rev."},{"issue":"7","key":"10.1016\/j.ijheh.2024.114402_bib14","doi-asserted-by":"crossref","first-page":"1508","DOI":"10.1177\/10781552211030682","article-title":"Validation of chemotherapy drug vapor containment of an air cleaning closed-system drug transfer device","volume":"28","author":"Levin","year":"2022","journal-title":"J. Oncol. Pharm. Pract."},{"issue":"320","key":"10.1016\/j.ijheh.2024.114402_bib15","article-title":"Suggestions for protecting breast cancer patients receiving outpatient chemotherapy and their families against the exposure risk from salivary cyclophosphamide","volume":"7","author":"Makino","year":"2020","journal-title":"Int. J. Nurs. Clin. Pract."},{"issue":"8","key":"10.1016\/j.ijheh.2024.114402_bib16","first-page":"530","article-title":"Exposure to anticancer drugs outside the hospital environment","volume":"63","author":"Meijster","year":"2006","journal-title":"Ann. Occup. Hyg."},{"issue":"3","key":"10.1016\/j.ijheh.2024.114402_bib17","doi-asserted-by":"crossref","first-page":"194","DOI":"10.2165\/00003088-199120030-00002","article-title":"Clinical pharmacokinetics of cyclophosphamide","volume":"20","author":"Moore","year":"1991","journal-title":"Clin. Pharmacokinet."},{"issue":"6","key":"10.1016\/j.ijheh.2024.114402_bib19","doi-asserted-by":"crossref","DOI":"10.1002\/pbc.29019","article-title":"High risk of hazardous drug exposure in caregivers of pediatric cancer patients","volume":"68","author":"Noda","year":"2021","journal-title":"Pediatr. Blood Cancer"},{"key":"10.1016\/j.ijheh.2024.114402_bib20","series-title":"Safe Handling of Hazardous Drugs","first-page":"18","author":"Polovich","year":"2017"},{"issue":"3","key":"10.1016\/j.ijheh.2024.114402_bib21","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1097\/JOM.0000000000000097","article-title":"Occpational exposure to cyclophasphamide in nurses at a single center","volume":"56","author":"Ramphal","year":"2012","journal-title":"J. Occup. Environ. Med."},{"issue":"6","key":"10.1016\/j.ijheh.2024.114402_bib22","first-page":"655","article-title":"Development of a substrate-activity based approach to identify the major human liver P-450 catalysts of cyclophosphamide and ifosfamide activation based on cDNA-expressed activities and liver microsomal P-450 profiles","volume":"27","author":"Roy","year":"1999","journal-title":"Drug Metab. Dispos."},{"key":"10.1016\/j.ijheh.2024.114402_bib23","article-title":"Environmental contamination with cytostatic drugs: past, present and future","author":"Sessink","year":"2011","journal-title":"Saf. Consid. Oncol. Pharm. Special edition"},{"issue":"10\u201311","key":"10.1016\/j.ijheh.2024.114402_bib24","first-page":"1061","article-title":"PLasma half-life and urinary excretion of cyclophosphamide in children","volume":"64","author":"Sladek","year":"1980","journal-title":"Cancer Treat Rep."},{"issue":"17","key":"10.1016\/j.ijheh.2024.114402_bib25","doi-asserted-by":"crossref","first-page":"2645","DOI":"10.1002\/rcm.3657","article-title":"Simultaneous determination of cyclophosphamide, ifosfamide, doxorubicin, epirubicin and daunorubicin in human urine using high-performance liquid chromatography\/electrospray ionization tandem mass spectrometry: bioanalytical method validation","volume":"22","author":"Sottani","year":"2008","journal-title":"Rapid Commun. Mass Spectrom."},{"issue":"1","key":"10.1016\/j.ijheh.2024.114402_bib26","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1007\/BF00405906","article-title":"Comparative study on human pharmacokinetics of activated ifosphamide and cyclophosphamide by a modified fluorometric test","volume":"100","author":"Wagner","year":"1981","journal-title":"J. Cancer Res. Clin. Oncol."},{"key":"10.1016\/j.ijheh.2024.114402_bib27","article-title":"Pediatric leukemia and maternal occupational exposure to anticancer drugs: the Japan Environment and Children's Study","author":"Yamamoto","year":"2023","journal-title":"Blood"},{"issue":"3","key":"10.1016\/j.ijheh.2024.114402_bib28","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1177\/1078155212459667","article-title":"Exposure of family members to anticancer drugs via excreta of treated cancer patients","volume":"19","author":"Yuki","year":"2013","journal-title":"J. Oncol. Pharm. Pract."},{"issue":"6","key":"10.1016\/j.ijheh.2024.114402_bib29","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1188\/15.ONF.42-06AP","article-title":"Secondary exposure of family members to cyclophosphamide after chemotherapy of outpatients with cancer: a pilot study","volume":"42","author":"Yuki","year":"2015","journal-title":"Oncol. Nurs. Forum"}],"container-title":["International Journal of Hygiene and Environmental Health"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S143846392400083X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S143846392400083X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,9,15]],"date-time":"2024-09-15T03:34:27Z","timestamp":1726371267000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S143846392400083X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,7]]},"references-count":28,"alternative-id":["S143846392400083X"],"URL":"https:\/\/doi.org\/10.1016\/j.ijheh.2024.114402","relation":{},"ISSN":["1438-4639"],"issn-type":[{"value":"1438-4639","type":"print"}],"subject":[],"published":{"date-parts":[[2024,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Cyclophosphamide exposure factors in family caregivers for pediatric cancer patients","name":"articletitle","label":"Article Title"},{"value":"International Journal of Hygiene and Environmental Health","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijheh.2024.114402","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier GmbH.","name":"copyright","label":"Copyright"}],"article-number":"114402"}}